NO792406L - Analogifremgangsmaate for fremstilling av substituerte 2-fenylamino-imidazoliner - Google Patents
Analogifremgangsmaate for fremstilling av substituerte 2-fenylamino-imidazolinerInfo
- Publication number
- NO792406L NO792406L NO792406A NO792406A NO792406L NO 792406 L NO792406 L NO 792406L NO 792406 A NO792406 A NO 792406A NO 792406 A NO792406 A NO 792406A NO 792406 L NO792406 L NO 792406L
- Authority
- NO
- Norway
- Prior art keywords
- acid
- general formula
- dichloro
- acid addition
- phenylamino
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- -1 2,6-dibromophenyl Chemical group 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 2
- UBEPBFYKYSULAI-UHFFFAOYSA-N 2-phenyl-2,5-dihydro-1H-imidazol-4-amine Chemical compound N1C(=N)CNC1C1=CC=CC=C1 UBEPBFYKYSULAI-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000003585 thioureas Chemical class 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- BNJBUDJCJPWKRQ-UHFFFAOYSA-H dipotassium;hexaiodoplatinum(2-) Chemical compound [K+].[K+].[I-].[I-].[I-].[I-].[I-].[I-].[Pt+4] BNJBUDJCJPWKRQ-UHFFFAOYSA-H 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- JCOPITWIWLFFPC-UHFFFAOYSA-N n-phenyl-4,5-dihydro-1h-imidazol-2-amine Chemical class N1CCN=C1NC1=CC=CC=C1 JCOPITWIWLFFPC-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- YIUIVFFUEVPRIU-UHFFFAOYSA-N 8-chlorotheophylline Chemical compound O=C1N(C)C(=O)N(C)C2=NC(Cl)=N[C]21 YIUIVFFUEVPRIU-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000059 bradycardiac effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001912 cyanamides Chemical class 0.000 description 1
- 150000001913 cyanates Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 150000002541 isothioureas Chemical class 0.000 description 1
- 150000002542 isoureas Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- XIVCHYWIEHVAJG-UHFFFAOYSA-N n-(2,6-dibromophenyl)-4,5-dihydro-1h-imidazol-2-amine Chemical compound BrC1=CC=CC(Br)=C1N=C1NCCN1 XIVCHYWIEHVAJG-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical class NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
"Analogifremgangsmåte for fremstilling av
substituerte 2- fenylamino- imidazoliner"
Denne oppfinnelse angår fremstilling av nye, substituerte 2-fenylamino-imidazolin-(2)-forbindelser med den generelle formel
og fysiologisk forlikelige syreaddisjonssalter derav med verdifulle/terapeutiske egenskaper..
I formel I betyr Ar resten 2,6-dibromfeny1, 2-fluor-6-trifluormetylfenyl, 2-fluor-6-klorfenyl, 2-klor-6-bromfenyl, 2,6-difluorfenyl, 2,4-diklorfenyl, 2-brom-3-klorfenyl, 2,6-diklor-4-hydroksykarbonylfenyl, 2,6-diklor-4-etoksykarbonylfenyl, 2,6-diklor-4-metoksyfenyl eller 2-brom-6-fluorfenyl.
Forbindelsene med formel I fremstilles ved:
a) Omsetning av et 2-fenylimino-imidazolidin med den
generelle formel
hvor Ar har de ovenfor angitte betydninger, med et halogenid med den generelle formel
hvor Hal betyr et klor-, brom- eller jodatom; eller
b) Omsetning av en forbindelse med den generelle formel
hvor Ar er som ovenfor angitt, og A betyr en cyanogrupppe eller
idet Y representerer en alkoksy- eller alkyltio-
gruppe med opptil 4 C-atomer eller en sulfhydryl- eller aminogruppe, med etylendiamin eller syreaddisjonssalter derav.
Ved alkyleringen av 2-arylimino-imidazolidinene med formel II ved fremgangsmåte a) skjer substitusjonen utelukkende på bro-nitrogenatomet. Ved omsetningen ifølge fremgangsmåte b)
er konstitusjonen av sluttforbindelsen fastlagt ved syntesen. Substituentenes stilling kan foruten ved syntesen også fastlegges ved NMR-spektroskopi. (kfr. H. Stahle og'K.H. Pook, Liebigs Ann. Chem. 751, 159 ff (1971) ) .
Omsetningen ifølge fremgangsmåte a) skjer hensiktsmessig ved oppvarmning av reaks jonskomponentene,' fortrinnsvis i nærvær av et polart eller upolart organisk oppløsningsmiddel, til temperaturer på ca. 50-150°C. De spesielle reaksjonsbetingelser er i sterk grad avhengig av reaktiviteten av reaksjpnskomponentene. Det anbefales å anvende halogenidet i overskudd ved alkyleringen
og utføre omsetningen i nærvær av et syrebindende middel.
Ved fremgangsmåte b) er det nødvendig å arbeide ved for-høyet temperatur, mellom 60 og 180°C. Oppløsningsmidler er ikke nødvendig. Det er hensiktsmessig at det som reaksjonskomponent anvendte etylendiamin resp. syreaddisjonssalter derav, anvendes i overskudd.
Utgangsforbindelser med formel II er f.eks. beskrevet
i de belgiske patenter 623.305, 687.657 og 705.944.
Forbindelser med formel IV får man ved å gå ut fra aniliner, ved omsetning med forbindelser med formel III og påfølgende omsetning av de derved dannede sekundære aminer med cyanater eller tiocyanater, hvorved henholdsvis urinstoffer eller tiourinstoffer dannes. Urinstoffer og tiourinstoffer kan derefter overføres videre med alkyleringsmidler til henholdsvis tilsvarende isouroniumsalter eller isotiouroniumsalter. Fra disse syreaddisjonsforbindelser kan man med baser utvinne henholdsvis de tilsvarende isourinstoffer eller isotiourinstoffer. Vannavspaltningen fra urinstoffer resp. I-^S-avspaltning fra tiourinstoffer med bly- eller kvikksølvsalter fører til cyan-amider, til hvilke ammoniakk kan tilleires under dannelse av guanidiner.
De nye 2-fenylamino-imidazolin-(2)-forbindelser med
den generelle formel I kan på vanlig måte overføres til sine fysiologisk forlikelige syreaddisjonssalter. Syrer som er egnet for saltdannelse, er f.eks. saltsyre, bromhydrogensyre, jod-hydrogensyre, fluorhydrogensyre, svovelsyre, fosforsyre, salpeter-syre, eddiksyre, propionsyre, smørsyre, kapronsyre, valeriansyre, oksalsyre, malonsyre, ravsyre, maleinsyre, fumarsyre, melkesyre, vinsyre, sitronsyre, eplesyre, benzoesyre, p-hydroksybenzoesyre, p-aminobenzoesyre, ftalsyre, kanelsyre, salicylsyre, askorbinsyre, metansulfonsyre, 8-klorteofyllin o.l.
De nye forbindelser med den generelle formel I og
deres syreaddisjonssalter har en sterk bradykard virkning og er derfor egnet til behandling av coronarlidelser. Innvirkning på hjertefrekvensen er undersøkt på kaniner og på spinalbedøvede rotter foruten intakte, narkotiserte rotter.
Doseringen ligger på 0,1 til 80 mg, fortrinnsvis 1 til 30 mg.
Forbindelsene med formel I og deres syreaddisjonssalter kan også anvendes sammen med andre aktive stoffer. Egnede galeniske tilberedelsesformer er f.eks. tabletter, kapsler, stikkpiller, oppløsninger eller pulvere, og for fremstillingen kan man anvende de vanlig anvendte galeniske hjelpestoffer, bæremidler, sprengmidler eller smøremidler eller stoffer som medfører en depotvirkning.
De følgende eksempler skal tjene til å illustrere oppfinnelsen ytterligere, uten å begrense den.
Eksempel 1
3, 5- diklor- 4-[ N-( allyl)- N-( 2- imidazoliny1-( 2)- amino]- benzoesyre
0,7 g (0,002045 mol) 3,5-diklor-4-[N-(allyl)-N-(2-imidazolinyl-(2))amino]-benzoesyreetylester oppvarmes sammen med 0,4 g (0,00716 mol) kaliumhydroksyd, 0,5 ml vann og 1 ml etanol 1 kort tid til 60°C. Derefter fortynnes med vann, reaksjons-blandingen befries for alkohol i vakuum, og oppløsningen bufres med iseddik til pH 5 efter filtrering. Det utfelte, hvite stoff avsuges og vaskes med vann og tørres. Ved utsaltning av moder-luten med koksalt, kan ytterligere mengder stoff utvinnes. Utbytte: 0,42 g (65,4% av det teoretiske), sm.p.: 321-323°C.
RF: 0,3, system: etylacetat 70, isopropanol 50, kons. NH^OI-I 20. Bærer: Silikagel G + lyspigment, detektor: UV og kaliumjodplatinat.
C13H13C12N3°2<314'17>
Beregnet: C 49,70, H 4,17, Cl 22,57, N 13,38%
Funnet: C 49,50, H 4,35, Cl 22,36, N 13,40%.
E ksempel 2
2 -[ N-( allyl)- N-( 2, 6- dibromfenyl)- amino]- 2- imidazolin
6,38 g (0,02 mol) 2-(2,6-dibromfenylimino)-imidazolidin oppvarmes sammen med 10 ml allylbromid i 25 ml metanol i 60 timer i et rør til 100°C. Efter avkjøling foreligger to faser. Den nedre fase (oljeaktig masse) oppløses i vann for videre opparbeidelse.
Oppløsningen ekstraheres derefter fraksjonert med eter ved stigende pH-verdier (trinnvis alkalisering med 2N natronlut). De tynnskikt-kromatografisk enhetlige eterekstrakter samles, tørres over MgSO^, frafiltreres og inndampes i vakuum. Derved utfelles først en olje som efter kort tid gjennomkrystalliserer (hvite krystaller). Utbytte: 1,6 g (22,3% av det teoretiske), sm.p.: 134-136°C.
RF: 0,5, system: benzen 50, dioksan 40, etanol"5, kons. NH^OH 5. Bærer: silikagel G + lyspigment, detektor: UV og kaliumjodplatinat.
C12H13Br2N3 (359,08)
Beregnet: C 40,14, H 3,65, Br 44,51, N 11,70%
Funnet:. C 40,26, H 3,60, Br 44 ,25 , N 11,49%.
Analogt med de foregående eksempler ble følgende forbindelser fremstilt. Smeltepunktene gjelder for basene med formel I med mindre saltformen er angitt.
Claims (1)
- Analogi fremgangsmåte for fremstilling av terapeutisk aktive substituerte 2-fenylamino-imidazolin-(2)-forbindelser med den generelle formelhvor Ar betyr resten 2,6-dibromfeny1, 2-fluor-6-trifluormetylfeny1, 2-fluor-6-klorfenyl, 2-klor-6-bromfenyl, 2,6-difluorfenyl, 2,4-diklorfeny1, 2-brom-3-klorfeny1, 2,6-diklor-4-hydroksy-karbonylfenyl, 2,6-diklor-4-etoksykarbonylfenyl, 2,6-diklor-4-metoksyfenyl eller 2-^brom-6-f luorfenyl, og syreaddisjonssalter derav, karakterisert ved at a) et 2-feny1-iminoimidazolidin med den generelle formelhvor Ar har de ovenfor angitte betydninger, omsettes med et allylhalogenid med den generelle formelhvor Hal betyr et klor-, brom- eller jodatom; ellerb) en forbindelse med den generelle formel hvor Ar er som ovenfor angitt, og A betyr en cyanogruppe eller restenhvor Y representerer en alkoksy- eller alkyltio- gruppe med opptil 4 karbonatomer eller en sulfhydryl- eller amino- gruppe, omsettes med etylendiamin eller syreaddisjonssaltet derav, og en forbindelse fremstilt som ovenfor angitt-, overføres eventuelt til et syreaddisjonssalt derav.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782832310 DE2832310A1 (de) | 1978-07-22 | 1978-07-22 | Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO792406L true NO792406L (no) | 1980-01-23 |
Family
ID=6045138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO792406A NO792406L (no) | 1978-07-22 | 1979-07-20 | Analogifremgangsmaate for fremstilling av substituerte 2-fenylamino-imidazoliner |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0007991A1 (no) |
| JP (1) | JPS5519272A (no) |
| AU (1) | AU4910179A (no) |
| DE (1) | DE2832310A1 (no) |
| DK (1) | DK307079A (no) |
| ES (1) | ES482742A1 (no) |
| FI (1) | FI792275A (no) |
| GR (1) | GR69649B (no) |
| IL (1) | IL57854A0 (no) |
| NO (1) | NO792406L (no) |
| NZ (1) | NZ191067A (no) |
| PT (1) | PT69952A (no) |
| ZA (1) | ZA793720B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4461904A (en) * | 1981-11-20 | 1984-07-24 | Alcon Laboratories, Inc. | 2-(Trisubstituted phenylimino)-imidazolines |
| US4644007A (en) * | 1981-11-20 | 1987-02-17 | Alcon Laboratories, Inc. | 3-chloro-4-(4,5-dihydro-1H-imidazo-2-yl)-amino-5-alkylbenzoic acids, esters, salts, compositions and methods |
| US4515800A (en) * | 1981-11-20 | 1985-05-07 | Icilio Cavero | Method of lowering intraocular pressure using phenylimino-imidazoles |
| US4517199A (en) * | 1981-11-20 | 1985-05-14 | Alcon Laboratories, Inc. | Method for lowering intraocular pressure using phenylimino-imidazoles |
| US7049326B2 (en) | 2000-05-12 | 2006-05-23 | The University Of Toledo | Method and compositions for temporarily incapacitating subjects |
| US6750238B1 (en) * | 2000-05-12 | 2004-06-15 | The University Of Toledo | Aralkyl ester soft drugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759125A (fr) * | 1969-11-19 | 1971-05-18 | Boehringer Sohn Ingelheim | Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer |
| DE2523103C3 (de) * | 1975-05-24 | 1979-11-29 | C.H. Boehringer Sohn, 6507 Ingelheim | Substituierte 2-[N-Progargyl-N-(2-chlorphenyl)amino] -imidazoline-^), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung |
-
1978
- 1978-07-22 DE DE19782832310 patent/DE2832310A1/de not_active Withdrawn
-
1979
- 1979-06-25 EP EP79102093A patent/EP0007991A1/de not_active Withdrawn
- 1979-07-18 GR GR59626A patent/GR69649B/el unknown
- 1979-07-20 PT PT69952A patent/PT69952A/pt unknown
- 1979-07-20 IL IL57854A patent/IL57854A0/xx unknown
- 1979-07-20 JP JP9250079A patent/JPS5519272A/ja active Pending
- 1979-07-20 AU AU49101/79A patent/AU4910179A/en not_active Abandoned
- 1979-07-20 NO NO792406A patent/NO792406L/no unknown
- 1979-07-20 ZA ZA00793720A patent/ZA793720B/xx unknown
- 1979-07-20 FI FI792275A patent/FI792275A/fi not_active Application Discontinuation
- 1979-07-20 DK DK307079A patent/DK307079A/da unknown
- 1979-07-20 NZ NZ191067A patent/NZ191067A/xx unknown
- 1979-07-21 ES ES482742A patent/ES482742A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2832310A1 (de) | 1980-02-07 |
| ZA793720B (en) | 1981-03-25 |
| PT69952A (de) | 1979-08-01 |
| FI792275A (fi) | 1980-01-23 |
| ES482742A1 (es) | 1980-04-16 |
| DK307079A (da) | 1980-01-23 |
| JPS5519272A (en) | 1980-02-09 |
| NZ191067A (en) | 1981-05-01 |
| EP0007991A1 (de) | 1980-02-20 |
| AU4910179A (en) | 1980-01-31 |
| GR69649B (no) | 1982-07-07 |
| IL57854A0 (en) | 1979-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2091135A1 (en) | Imidazole derivatives with a biphenylsulfonylurea or biphenylsulfonylurethane side chain, process for their preparation and their use | |
| NO128569B (no) | ||
| NO136360B (no) | ||
| NO145275B (no) | Analogifremgangsmaate for fremstilling av imidazolinderivater og deres syreaddisjonssalter | |
| US4250186A (en) | Method of slowing heart rate | |
| RU1797610C (ru) | Способ получени (2-морфолинофенил)гуанидинов или их фармацевтически приемлемых солей | |
| NO792406L (no) | Analogifremgangsmaate for fremstilling av substituerte 2-fenylamino-imidazoliner | |
| US4213995A (en) | 2-Phenylimino-imidazolidines and salts thereof | |
| DE1957722A1 (de) | Neue substituierte N-Aminoalkyl-arylaminoimidazoline-(2) und Verfahren zu deren Herstellung | |
| NO143459B (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive 2-fenylimino-imidazolidin-derivater | |
| NO792334L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylamino-imidazol-derivater | |
| HU185457B (en) | Process for preparating cimetidine-z | |
| EP0007438B1 (de) | Neue substituierte 2-Phenylamino-imidazoline-(2), deren Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zur Herstellung derselben | |
| NO150436B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenylamino-imidazolin-derivater | |
| NO792276L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenylamino-imidazolin-(2)-derivater | |
| EP0072954A2 (de) | Isoindolin-2-yl-amino-imidazoline und Isoindolin-2-yl-guanidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| NO128570B (no) | ||
| US4166184A (en) | 2h-imidazole-2-thione derivatives | |
| NO792368L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylamino-imidazolin-derivater | |
| JPS6030310B2 (ja) | イミダゾールの製法 | |
| NO151412B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylamino-imidazolin-derivater | |
| EP0007024B1 (de) | Neue substituierte 2-Phenylamino-1,3-tetrahydropyrimidine-(2), deren Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zur Herstellung derselben | |
| EP0083729B1 (de) | Substituierte 1-Benzoyl-2-phenylimino-imidazolidine, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| US4063023A (en) | Process for preparing 4-(hydroxymethyl)imidazole compounds | |
| EP0007986B1 (de) | Neue substituierte 2-Phenylamino-imidazoline-(2), deren Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zur Herstellung derselben |